Literature DB >> 20636245

History of preeclampsia is not associated with an increased risk of thyroid dysfunction.

Ruth R Dekker1, Bram M Jochemsen, Maria G van Pampus, Job G Santema, Caroline Roozendaal, Henk Groen, Thera P Links, Jasper J van Doormaal.   

Abstract

OBJECTIVE: We evaluated the thyroid function in women with a history of preeclampsia and/or HELLP syndrome at least 2 years after delivery.
DESIGN: Observational retrospective study.
SETTING: University Medical Center Groningen, The Netherlands. POPULATION: Women with a history of preeclampsia and/or HELLP syndrome (n = 310) or uncomplicated pregnancies (n = 363), between January 1990 and February 2003.
METHODS: Measurement of serum thyroid stimulating hormone (TSH) levels and antibodies to thyroid peroxidase and the use of a questionnaire about relevant history and family history of auto-immune diseases related to thyroid disease. MAIN OUTCOME MEASURES: Prevalence of primary thyroid dysfunction and antibodies to thyroid peroxidase.
RESULTS: Mean serum TSH values were not significantly different between the preeclampsia and control group (1.62 vs. 1.80 mU/l). The percentage of women who have (have had) hypothyroidism and hyperthyroidism, respectively, did not differ significantly between the preeclampsia and the control group (3.3 vs. 6.1% and 10.0 vs. 7.7%). Furthermore the prevalence of antibodies to thyroid peroxidase was not significantly different (6.1 vs. 7.7%).
CONCLUSION: Preeclampsia and/or HELLP syndrome are not associated with an increased risk of thyroid dysfunction in later life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20636245     DOI: 10.3109/00016349.2010.500367

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  1 in total

1.  Preeclampsia, gestational hypertension and subsequent hypothyroidism.

Authors:  Tuija Männistö; S Ananth Karumanchi; Anneli Pouta; Marja Vääräsmäki; Pauline Mendola; Satu Miettola; Heljä-Marja Surcel; Aini Bloigu; Aimo Ruokonen; Marjo-Riitta Järvelin; Anna-Liisa Hartikainen; Eila Suvanto
Journal:  Pregnancy Hypertens       Date:  2012-09-21       Impact factor: 2.899

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.